Doug Drysdale (@insidepharma) 's Twitter Profile
Doug Drysdale

@insidepharma

CEO @CybinInc (NYSE:CYBN) | Changing Minds | E&Y Entrepreneur of the Year | Inc. 5000 | Healthcare Investor & Advisor

ID: 298850585

linkhttps://cybin.com calendar_today15-05-2011 02:05:15

2,2K Tweet

2,2K Takipçi

510 Takip Edilen

Psychedelic Vantage (@psychedvantage) 's Twitter Profile Photo

“There are ongoing clinical trials that are going to read out, sometime soon, and we have to take an expeditious and rapid review of that data” - FDA commissioner, Dr. Marty Makary $GHRS $MNMD $CMPS $ATAI $CYBN

Psychedelic Alpha (@psyched_alpha) 's Twitter Profile Photo

FDA Commissioner Martin Makary broke his silence on psychedelics on Friday, making his first public comments on the topic since taking the role. Read our coverage and analysis: psychedelicalpha.com/news/fdas-maka…

FDA Commissioner Martin Makary broke his silence on psychedelics on Friday, making his first public comments on the topic since taking the role.

Read our coverage and analysis: psychedelicalpha.com/news/fdas-maka…
CybinInc (@cybininc) 's Twitter Profile Photo

“It is gratifying that the U.S. FDA Commissioner Dr. Martin Makary shares our belief in the potential therapeutic value of these innovative treatments – a long-held belief that stands at the core of Cybin’s mission,” said Doug Drysdale, Chief Executive Officer of Cybin. Watch Dr.

“It is gratifying that the <a href="/US_FDA/">U.S. FDA</a> Commissioner <a href="/DrMakaryFDA/">Dr. Martin Makary</a> shares our belief in the potential therapeutic value of these innovative treatments – a long-held belief that stands at the core of Cybin’s mission,” said <a href="/insidepharma/">Doug Drysdale</a>, Chief Executive Officer of Cybin.

Watch Dr.
Daniel Carcillo (@carbombboom13) 's Twitter Profile Photo

BREAKING: The FDA Commissioner under the Trump administration says exploring psychedelic medicine is a “top priority.” U.S. FDA This is historic. For years, veterans and their families have suffered while Washington sat on its hands. That’s finally changing. Thanks to

Water Tower Research LLC (@wtr_research) 's Twitter Profile Photo

Please join Robert Sassoon for a fireside chat with CybinInc Chief Executive Officer Doug Drysdale on Thursday, May 29, 2025, at 11:00 am ET. Register below! us06web.zoom.us/webinar/regist… $CYBN #FiresideChat #Psychedelics #SmallCap #Stocks #Investing

Please join Robert Sassoon for a fireside chat with <a href="/CybinInc/">CybinInc</a> Chief Executive Officer <a href="/insidepharma/">Doug Drysdale</a> on Thursday, May 29, 2025, at 11:00 am ET. Register below!

us06web.zoom.us/webinar/regist…

$CYBN #FiresideChat #Psychedelics #SmallCap #Stocks #Investing
Power (@withpowerhq) 's Twitter Profile Photo

💬 “With regular psilocybin, you might be waiting an hour... with our deuterated psilocin, we see effects in about 15 minutes.” -Doug Drysdale, CEO of CybinInc modified psychedelics could lead to faster, scalable treatments 🎧 withpower.com/hub/podcast/go…

CybinInc (@cybininc) 's Twitter Profile Photo

#Cybin CEO Doug Drysdale will discuss partnerships, progress on #CYB003, upcoming milestones, and the #FDA and #psychedelics in a Water Tower Research LLC Fireside Chat next week, Thursday, May 29, 2025. Click here to register for the webcast: loom.ly/ORTJqz4

Secretary Kennedy (@seckennedy) 's Twitter Profile Photo

I recently met with mental health advocates and insurers during Mental Health Awareness Month. We’re spending billions on treatments—but too often, we don’t know if they’re working. That’s unacceptable. We’re building an outcomes-based system that delivers real results for

Doug Drysdale (@insidepharma) 's Twitter Profile Photo

On this Memorial Day weekend, I pause to honor the brave men and women who made the ultimate sacrifice for our freedom. Their courage and selflessness are the foundation upon which we build our mission to transform mental health care. The freedoms they secured allow us to

Dr. Martin Makary (@drmakaryfda) 's Twitter Profile Photo

We’re going on a national listening tour to meet directly with pharmaceutical and biotech CEOs. This is a chance for the FDA to listen and gather feedback from those at the front lines of discovery. We are committed to strengthening a regulatory environment that enables

Doug Drysdale (@insidepharma) 's Twitter Profile Photo

It is with profound admiration and gratitude, as a fellow traveler in the realm of psychedelic research, to honor Amanda Feilding’s extraordinary contributions to our field. The name, Amanda Feilding, has become synonymous with the psychedelic renaissance—a movement she helped

It is with profound admiration and gratitude, as a fellow traveler in the realm of psychedelic research, to honor Amanda Feilding’s extraordinary contributions to our field. The name, Amanda Feilding, has become synonymous with the psychedelic renaissance—a movement she helped
CybinInc (@cybininc) 's Twitter Profile Photo

“On this Memorial Day, I pause to honor the brave men and women who made the ultimate sacrifice for our freedom. Their courage and selflessness are the foundation upon which we build our mission to transform mental health care. The freedoms they secured allow us to innovate,

“On this Memorial Day, I pause to honor the brave men and women who made the ultimate sacrifice for our freedom. Their courage and selflessness are the foundation upon which we build our mission to transform mental health care. The freedoms they secured allow us to innovate,
AdvisorShares (@advisorshares) 's Twitter Profile Photo

#AlphaNooner Live TOMORROW! at 12PM ET with Doug Drysdale Doug Drysdale CEO of CybinInc and Mackenzie Peterson Mackenzie P talking $CYBN #Psychedelics #MentalHealth #Wellness #Therapeutics

#AlphaNooner Live TOMORROW! at 12PM ET with Doug Drysdale <a href="/insidepharma/">Doug Drysdale</a> CEO of <a href="/CybinInc/">CybinInc</a> and Mackenzie Peterson <a href="/mpadvisorshares/">Mackenzie P</a> talking $CYBN #Psychedelics #MentalHealth #Wellness #Therapeutics
CybinInc (@cybininc) 's Twitter Profile Photo

#ICYMI: Last week, Cybin CEO Doug Drysdale was featured in a fireside chat hosted by Jim Molloy at Alliance Global Partners (A.G.P.)'s Virtual Healthcare Showcase. Tune in to the replay to learn more about Cybin's progress with its lead clinical-stage programs CYB003 and CYB004,

#ICYMI: Last week, Cybin CEO <a href="/insidepharma/">Doug Drysdale</a> was featured in a fireside chat hosted by Jim Molloy at Alliance Global Partners (A.G.P.)'s Virtual Healthcare Showcase. Tune in to the replay to learn more about Cybin's progress with its lead clinical-stage programs CYB003 and CYB004,
John Maraganore 🇺🇦🇮🇱 (@jmaraganore) 's Twitter Profile Photo

“In the 1990s, the U.S. fell behind in the semiconductor chip race. Now, leaders need to invest in biotech.” Source: TIME share.google/0kI3RrZc18wF6m…

OutKick (@outkick) 's Twitter Profile Photo

Today on Tomi Lahren is Fearless: - Power of Psychedelics - Ketamine Benefits - Cybin CEO Doug Drysdale Joins - Big Pharma Breakthrough? - Symptom vs Cause? - Tricking Mental Illness x.com/i/broadcasts/1…